390 related articles for article (PubMed ID: 10437389)
1. [The effect of intrabronchial specific immunotherapy on certain immunologic parameters in asthmatic patients with allergic to house mites].
Zietkowski Z
Pol Merkur Lekarski; 1999 May; 6(35):236-8. PubMed ID: 10437389
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma].
Zietkowski Z
Pol Merkur Lekarski; 1999 May; 6(35):239-41. PubMed ID: 10437390
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
4. Analysis of house dust mite-specific IgE, IgG4, and IgG antibodies during immunotherapy in asthmatic children.
Lin KL; Wang SY; Hsieh KH
Ann Allergy; 1991 Jul; 67(1):63-9. PubMed ID: 1859043
[TBL] [Abstract][Full Text] [Related]
5. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.
Machiels JJ; Somville MA; Lebrun PM; Lebecque SJ; Jacquemin MG; Saint-Remy JM
J Clin Invest; 1990 Apr; 85(4):1024-35. PubMed ID: 2318962
[TBL] [Abstract][Full Text] [Related]
6. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
7. [Specific IgG and IgE antibodies in house dust mite asthmatic patients and control probands].
Sarvan M; Noyan O; Debelić M
Pneumologie; 1990 Feb; 44 Suppl 1():375-7. PubMed ID: 2367421
[TBL] [Abstract][Full Text] [Related]
8. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
[TBL] [Abstract][Full Text] [Related]
10. IgG, IgA, IgM and IgE serum levels in asthmatic patients sensitive to house dust and mite allergens after two-year specific immunotherapy.
Szymański W; Chyrek-Borowska S; Obrzut D
Arch Immunol Ther Exp (Warsz); 1984; 32(4):381-7. PubMed ID: 6534314
[TBL] [Abstract][Full Text] [Related]
11. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
12. Influence of hyposensitization with Dermatophagoides pteronyssinus extract on clinical score, total and specific IgE levels, and skin test in asthmatic patients.
Delaunois L; Salamon E; Prignot J
Ann Allergy; 1985 Aug; 55(2):150-2. PubMed ID: 4025957
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
14. Effect of immunotherapy on antigen-specific IgG4 in asthmatics sensitive to D. pteronyssinus.
García BE; Sanz ML; Wong E; Oehling A
Allergol Immunopathol (Madr); 1988; 16(6):379-83. PubMed ID: 3242375
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma--a double-blind study.
Tari MG; Mancino M; Monti G
J Investig Allergol Clin Immunol; 1992; 2(2):59-67. PubMed ID: 1342886
[TBL] [Abstract][Full Text] [Related]
16. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
Nagata M; Tanaka K
Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
[TBL] [Abstract][Full Text] [Related]
17. Immunologic evaluation of 24 month course of sublingual immunotherapy.
Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
[TBL] [Abstract][Full Text] [Related]
18. Cat and dust mite sensitivity and tolerance in relation to wheezing among children raised with high exposure to both allergens.
Erwin EA; Wickens K; Custis NJ; Siebers R; Woodfolk J; Barry D; Crane J; Platts-Mills TA
J Allergy Clin Immunol; 2005 Jan; 115(1):74-9. PubMed ID: 15637550
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of rapid injection immunotherapy by antigen specific IgE and IgG4 antibodies].
Satoh Y; Sugimoto K; Kuroki H; Fuzimoto N; Suzuki H
Arerugi; 1989 Mar; 38(3):246-53. PubMed ID: 2751431
[TBL] [Abstract][Full Text] [Related]
20. Lack of specific IgE against house-dust and Dermatophagoides pteronyssinus in aspirin-sensitive asthmatics with positive skin and inhalation test.
Swatko A; Grzelewska-Rzymowska I; Rozniecki J; Szmidt M
Allergol Immunopathol (Madr); 1982; 10(4):277-82. PubMed ID: 7180793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
